Last reviewed · How we verify
Sublingual film containing Dexmedetomidine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Sublingual film containing Dexmedetomidine (Sublingual film containing Dexmedetomidine) — BioXcel Therapeutics Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sublingual film containing Dexmedetomidine TARGET | Sublingual film containing Dexmedetomidine | BioXcel Therapeutics Inc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sublingual film containing Dexmedetomidine CI watch — RSS
- Sublingual film containing Dexmedetomidine CI watch — Atom
- Sublingual film containing Dexmedetomidine CI watch — JSON
- Sublingual film containing Dexmedetomidine alone — RSS
Cite this brief
Drug Landscape (2026). Sublingual film containing Dexmedetomidine — Competitive Intelligence Brief. https://druglandscape.com/ci/sublingual-film-containing-dexmedetomidine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab